HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USPSTF Doesn’t See Forest Of VMS Benefits For Trees Of Reducing Cancer, Heart Disease Risks

Executive Summary

US Preventative Services Task Force concludes evidence doesn't support  recommending VMS use to prevent cancer or cardiovascular disease. Trade groups and a natural medicine expert say task force's focus is narrow and its recommendation misleading. 

You may also be interested in...



Health Concerns Survey Shows More Than Half US Parents Provide Supplements For Children

Nationwide survey on parent's concerns about children’s health care found 52% of children regularly use supplements, and almost 80% of parents want supplements regulated by FDA.

Dietary Guidelines Should Endorse Regular Vitamin Use – CRN

“Using a multivitamin-mineral to fill [nutrient] gaps is a prudent way to make sure that Americans meet their targeted nutrient intakes,” says CRN science chief Duffy MacKay. The Dietary Guidelines Advisory Committee meets Sept. 16-17 for the final time before submitting its report to HHS and USDA.

HHS Supplement Report Conclusions Need Revision, Trade Groups Say

Recent draft guidance issued by the USPSTF has supplement industry groups calling for revisions that will reflect a more positive light on nutritional ingredients and that won’t be misinterpreted by consumers.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152659

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel